LOPINAVIR; RITONAVIR | N021906 | ABBVIE INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2017-08-24 | Terminated 2017-10-25 | — | |
| D. Del. | 2017-01-13 | Terminated 2017-02-24 | — | |
| D. Del. | 2015-10-02 | Terminated 2015-10-27 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Matrix Laboratories, Inc. - Citizen Petition FDA-2007-P-0405 · 6 docket documents Matrix Laboratories Limited, India, submitted this suitability petition pursuant to 21 CFR 10.20, 10.30, 314.93 and section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting FDA approval to submit an Abbreviated New Drug Application for lopinavir/ritonavir tablets at a lower streng | Other | 2008-06-12 | Withdrawn | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.